Genetic testing for diffuse lung diseases in children
© 2023 Wiley Periodicals LLC..
Newly developing genomic technologies are an increasingly important part of clinical care and thus, it is not only important to understand the technologies and their limitations, but to also interpret the findings in an actionable fashion. Clinical geneticists and genetic counselors are now an integral part of the clinical team and are able to bridge the complexities of this rapidly changing science between the bedside clinicians and patients. This manuscript reviews the terminology, the current technology, some of the known genetic disorders that result in lung disease, and indications for genetic testing with associated caveats. Because this field is evolving quickly, we also provide links to websites that provide continuously updated information important for integrating genomic technology results into clinical decision-making.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Pediatric pulmonology - (2023) vom: 16. Mai |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hamvas, Aaron [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Childhood |
|---|
| Anmerkungen: |
Date Revised 19.05.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1002/ppul.26447 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356940055 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356940055 | ||
| 003 | DE-627 | ||
| 005 | 20231226071524.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ppul.26447 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM356940055 | ||
| 035 | |a (NLM)37191361 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hamvas, Aaron |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Genetic testing for diffuse lung diseases in children |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023 Wiley Periodicals LLC. | ||
| 520 | |a Newly developing genomic technologies are an increasingly important part of clinical care and thus, it is not only important to understand the technologies and their limitations, but to also interpret the findings in an actionable fashion. Clinical geneticists and genetic counselors are now an integral part of the clinical team and are able to bridge the complexities of this rapidly changing science between the bedside clinicians and patients. This manuscript reviews the terminology, the current technology, some of the known genetic disorders that result in lung disease, and indications for genetic testing with associated caveats. Because this field is evolving quickly, we also provide links to websites that provide continuously updated information important for integrating genomic technology results into clinical decision-making | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a childhood | |
| 650 | 4 | |a genetic testing | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a interstitial lung disease | |
| 650 | 4 | |a respiratory distress syndrome | |
| 700 | 1 | |a Chaudhari, Bimal P |e verfasserin |4 aut | |
| 700 | 1 | |a Nogee, Lawrence M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric pulmonology |d 1993 |g (2023) vom: 16. Mai |w (DE-627)NLM012888230 |x 1099-0496 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:16 |g month:05 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ppul.26447 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 16 |c 05 | ||